Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345593C Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/31/2007CN100345543C Use of plant growth regulator for insect
10/31/2007CN100345541C Microcapsules for the delayed, controlled release of perindopril
10/31/2007CN100345536C Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid
10/30/2007US7288654 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288567 Inhibitors of histone deacetylase
10/30/2007US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease
10/30/2007US7288565 Azasugar compound
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288550 Administering 2-butyl-1-[5-(methylsulfonyl)pentyl]-1H-imidazo[4,5-c]quinolin-4-amine or salts to induce biosynthesis of cytokines such as IFN- alpha and/or TNF- alpha; treating viral diseases
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288251 Antibodies to CD40
10/30/2007CA2451433C Oligopeptide transporter 1 inhibitor
10/30/2007CA2421548C Amidine inhibitors of serine proteases
10/30/2007CA2416212C Indole derivatives useful for the treatment of cns disorders
10/30/2007CA2382106C Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/30/2007CA2220012C Methods for modulating t cell survival by modulating bcl-xl protein level
10/30/2007CA2186757C Use of biopolymers for digestive tract injuries treatment
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119887A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
10/25/2007WO2007119837A1 Lipase inhibitor
10/25/2007WO2007119833A1 Nitrogen-containing heterocyclic compound
10/25/2007WO2007119815A1 Toll-like receptor 9 agonists
10/25/2007WO2007119799A1 Marker for detecting myocardial differentiation activity of cell
10/25/2007WO2007119789A1 Agent for suppressing arteriosclerosis
10/25/2007WO2007119787A1 Phosphatase involved in the regulation of cardiomyocyte differentiation
10/25/2007WO2007119693A1 Lactic acid bacterium-derived composition for ppar-dependent gene transcription activation
10/25/2007WO2007119692A1 METHOD OF INHIBITING CANCER CELL PROLIFERATION BY REGULATING eIF4H EXPRESSION
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119656A1 Tamsulosin-containing percutaneous absorption type preparation
10/25/2007WO2007119588A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007WO2007119578A1 Agent for improving nervous system cell functions
10/25/2007WO2007119564A1 siRNA SPECIFIC TO WT1 17AA(-)ISOFORM AND USE THEREOF
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119503A1 Wake-up remedy
10/25/2007WO2007119447A1 Therapeutic agent for rheumatoid arthritis
10/25/2007WO2007119367A1 Composition containing biopterin and method for using the same
10/25/2007WO2007076070A3 Modulators of muscarinic receptors
10/25/2007WO2006105998A3 Treatment of cognitive and learning impairment
10/25/2007WO2003011210A3 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070249822 Photolabile Coumarinylmethyl Esters of Cyclic Nucleotides, Methods for their Preparation and Their Use
10/25/2007US20070249702 Calcilytic compounds
10/25/2007US20070249692 Inhibitors of crystallization in a solid dispersion
10/25/2007US20070249667 Use of Substituted Quinoline Derivatives for the Treatment of Drug Resistant Mycobacterial Diseases
10/25/2007US20070249663 Corticotropin-Releasing Factor (CRF) receptor antagonist as therapeutic agent for depression, depressive symptom, or irritable bowel syndrome
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249622 Nicotinic receptor agonists and analogues and derivatives thereof for the treatment of inflammatory diseases
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249613 Reduction of Toxicity of Multi-Targeting Antifolates
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249594 Benzothiazine and benzothiadiazine compounds
10/25/2007US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders
10/25/2007US20070249586 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070249559 Hydrating Composition
10/25/2007US20070249553 Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter
10/25/2007US20070249537 Absorption enhancing agents
10/25/2007US20070249527 autoimmune diseases; antiarthritic agents; inflammatory bowel disorders; psoriasis; antiallergens; chronic obstructive pulmonary disease; antiallergens
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule
10/25/2007US20070248701 Methods and formulations for inhibiting naturally occurring phosphodiesterase
10/25/2007US20070248659 Individualized cancer therapy
10/25/2007US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248590 Modulators of CDC2-like kinases (CLKS) and methods of use thereof
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007US20070248538 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/25/2007CA2649735A1 Activating agent for peroxisome proliferator activated receptor .delta.
10/25/2007CA2649315A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2646620A1 Therapeutic agent for rheumatoid arthritis
10/24/2007EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847548A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847533A1 Six-membered heterocyclic compound and the use thereof
10/24/2007EP1847531A1 Pyrazole compound
10/24/2007EP1847527A1 Novel benzamidine compound
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1847244A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1846424A1 Proteasome inhibitors and methods of using the same
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1478784B1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
10/24/2007EP1471899B1 Use of ambroxol in the treatment of chronic pain
10/24/2007EP1432728A4 Methods and compositions for treating inflammatory disorders
10/24/2007EP1365771B1 Method of treating certain eye diseases
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 1564